Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuan Hong

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Bioorganic & Medicinal Chemistry Letters|November 4, 2011
CCR2 receptor antagonists: optimization of biaryl sulfonamides to increase activity in whole bloodGren Z Wang, Pamela A Haile, Tom Daniel, et al.
Journal of Medicinal Chemistry|January 29, 2019
Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS MethodologiesGraham L Simpson, Sophie M Bertrand, Jennifer A Borthwick, et al.
Assay and Drug Development Technologies|June 19, 2013
Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylationMartin Brandt, Lawrence M Szewczuk, Hong Zhang, et al.
Journal of Medicinal Chemistry|July 26, 2012
Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)Jeffrey M Axten, Jesús R Medina, Yanhong Feng, et al.
Chemistry & Biology|February 23, 2011
Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding siteJingsong Yang, Nino Campobasso, Mangatt P Biju, et al.
Nature Chemical Biology|March 26, 2013
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding groupMercedes Lobera, Kevin P Madauss, Denise T Pohlhaus, et al.
Biotechnology and Bioengineering|April 8, 2020
Highland games: A benchmarking exercise in predicting biophysical and drug properties of monoclonal antibodies from amino acid sequencesJonathan Coffman, Bruno Marques, Raquel Orozco, et al.
Cancer Cell|December 12, 2018
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung CancerPei-Chih Lee, Yueh-Fu Fang, Hirohito Yamaguchi, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Bioorganic & Medicinal Chemistry Letters|November 4, 2011
CCR2 receptor antagonists: optimization of biaryl sulfonamides to increase activity in whole bloodGren Z Wang, Pamela A Haile, Tom Daniel, et al.
Journal of Medicinal Chemistry|January 29, 2019
Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS MethodologiesGraham L Simpson, Sophie M Bertrand, Jennifer A Borthwick, et al.
Assay and Drug Development Technologies|June 19, 2013
Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylationMartin Brandt, Lawrence M Szewczuk, Hong Zhang, et al.
Journal of Medicinal Chemistry|July 26, 2012
Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)Jeffrey M Axten, Jesús R Medina, Yanhong Feng, et al.
Chemistry & Biology|February 23, 2011
Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding siteJingsong Yang, Nino Campobasso, Mangatt P Biju, et al.
Nature Chemical Biology|March 26, 2013
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding groupMercedes Lobera, Kevin P Madauss, Denise T Pohlhaus, et al.
Biotechnology and Bioengineering|April 8, 2020
Highland games: A benchmarking exercise in predicting biophysical and drug properties of monoclonal antibodies from amino acid sequencesJonathan Coffman, Bruno Marques, Raquel Orozco, et al.
Cancer Cell|December 12, 2018
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung CancerPei-Chih Lee, Yueh-Fu Fang, Hirohito Yamaguchi, et al.
Pageof 15